Forbes

Hundreds of cases and one death have been reported in Florida from dengue fever. A doctor breaks down symptoms to watch for and how to prevent it.

A test of 511 AI-designed antibodies shows AI can improve promising drug candidates, but lab experiments remain essential for discovering safe, developable antibodies.

A conversation with two leading neurologists share actionable insights on proactive baselining, lifestyle rigor, and sensory health to protect cognitive function.

Marketed for over a decade as a natural wellness product, kratom contains mitragynine and its derivative 7-hydroxymitragynine, which both interact with opioid receptors.

Cornell’s sexual assault allegations echo a case from 41 years ago, exposing how little has changed in who bears the consequences when campus systems fail.

Sexual assault can affect physical and mental health for months or years. Here’s what survivors may face—and what good healthcare should provide.

While Pharmacy First could partially relieve wait times at GP offices and emergency rooms, it’s sidestepping the larger chronic problem of NHS underfunding.

The question becomes whether firms will respond by withdrawing drugs from certain markets or delaying launches of their newly approved drugs in these jurisdictions.

As Breast Cancer Awareness Month begins, women diagnosed today benefit from decades of progress in care. However, innovation does not automatically create health equity.

Emicizumab, a bispecific antibody that bridges clotting factors IX and X, restores factor VIII function and prevents bleeding in hemophilia A with infrequent injections.

AI risk isn't only about models. Data center concentration and shared digital infrastructure can increase the blast radius when systems fail.

Training for a half marathon? Learn why sunscreen for Black skin matters, plus how to prevent the chafing and dark spots that come with long runs.

Health insurers in privatized Medicare Advantage are for the most part maintaining their 2027 geographic footprints after a multi-year period of retrenchment.

Sufferers of complex, chronic diseases like POTS and long COVID often spend years searching for relief. The longtime tech exec started ChronicleBio to find treatments using AI and lots of biological data.